Noninvasive fluorescence monitoring of protoporphyrin IX production and clinical outcomes in actinic keratoses following short-contact application of 5-aminolevulinate

Journal of Biomedical Optics

Volumn 15, Issue 5, 2010, Pages

  Warren, Christine B ^a   Lohser, Sara ^a   Wene, Lauren C ^a   Pogue, Brian W ^b   Bailin, Philip L ^a   Maytin, Edward V ^a,c,d  

^a LERNER RESEARCH INSTITUTE   (United States)

^b DARTMOUTH COLLEGE   (United States)

^c Department of Biomedical Engineering ^*  (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Fiber optic applications; Fluorescence; Medicine; Photodetection; Photometry

Indexed keywords

5-AMINOLEVULINATE; 5-AMINOLEVULINIC ACID; ACTINIC KERATOSIS; CLINICAL OUTCOME; FIBER OPTIC APPLICATIONS; FLUORESCENCE MEASUREMENTS; FLUORESCENT SIGNALS; LINEAR KINETICS; OPTIMAL TIME; PHOTO DETECTION; PROTOPORPHYRIN IX; SHORT CONTACTS; SKIN LESION;

DERMATOLOGY; KINETICS; MONITORING; PHOTODYNAMIC THERAPY;

FLUORESCENCE;

AMINOLEVULINIC ACID; PROTOPORPHYRIN;

ACTINIC KERATOSIS; AGED; ARTICLE; BIOSYNTHESIS; BLEACHING; ERYTHEMA; FEMALE; FLUORESCENCE; HUMAN; MALE; METABOLISM; METHODOLOGY; MIDDLE AGED; PATHOLOGY; PHOTOCHEMOTHERAPY; TOPICAL DRUG ADMINISTRATION; TREATMENT OUTCOME;

ADMINISTRATION, TOPICAL; AGED; AMINOLEVULINIC ACID; ERYTHEMA; FEMALE; FLUORESCENCE; HUMANS; KERATOSIS, ACTINIC; MALE; MIDDLE AGED; PHOTOBLEACHING; PHOTOCHEMOTHERAPY; PROTOPORPHYRINS; TREATMENT OUTCOME;

EID: 79952527171     PISSN: 10833668     EISSN: 15602281     Source Type: Journal    
DOI: 10.1117/1.3484255     Document Type: Article

References (20)

1. M. A. MacCormack, "Photodynamic therapy," Adv. Dermatol. 22, 219-258 (2006).
2. L. R. Braathen, R. M. Szeimies, N. Basset-Seguin, R. Bissonnette, P. Foley, D. Pariser, R. Roelandts, A. M. Wennberg, and C. A. Morton, "Guidelines on the use of photodynamic therapy for nonmelanoma skin cancer: an international consensus. International Society for Photodynamic Therapy in Dermatology, 2005," J. Am. Acad. Dermatol. 56(1), 125-143 (2007).
3. J. E. Blume and A. R. Oseroff, "Aminolevulinic acid photodynamic therapy for skin cancers," Dermatol. Clin. 25(1), 5-14 (2007).
4. DUSA Pharmaceuticals, "Levulan Kerastick topical solution 20%," package insert (http://www.dusapharma.com) (accessed June 7, 2009).
5. D. Touma, M. Yaar, S. Whitehead, N. Konnikov, and B. A. Gilchrest, "A trial of short incubation, broad-area photodynamic therapy for facial actinic keratoses and diffuse photodamage," Arch. Dermatol. 140(1), 33-40 (2004).
6. M. H. Gold, "Photodynamic therapy in dermatology: the next five years," Dermatol. Clin. 25(1), 119-120 (2007).
7. A. Itkin and B. A. Gilchrest, "Delta-aminolevulinic acid and blue light photodynamic therapy for treatment of multiple basal cell carcinomas in two patients with nevoid basal cell carcinoma syndrome," Dermatol. Surg. 30(7), 1054-1061 (2004).
8. K. P. Redbord and C. W. Hanke, "Topical photodynamic therapy for dermatologic disorders: results and complications," J. Drugs Dermatol. 6(12), 1197-1202 (2007).
9. C. B. Warren, L. J. Karai, A. Vidimos, and E. V. Maytin, "Pain associated with aminolevulinic acid-photodynamic therapy of skin disease," J. Am. Acad. Dermatol. 61(6), 1033-1043 (2009).
10. B. W Pogue and G. Burke, "Fiber-optic bundle design for quantitative fluorescence measurement from tissue," Appl. Opt. 37(31), 7429-7436 (1998).
11. X. Zhou, B. W. Pogue, B. Chen, E. Demidenko, R. Joshi, J. Hoopes, and T. Hasan, "Pretreatment photosensitizer dosimetry reduces variation in tumor response," Int. J. Radiat. Oncol., Biol., Phys. 64(4), 1211-1220 (2006).
12. C. Sheng, P. J. Hoopes, T. Hasan, and B. W Pogue, "Photobleaching- based dosimetry predicts deposited dose in ALA-PpIX PDT of rodent esophagus," Photochem. Photobiol. 83(3), 738-748 (2007).
13. S. Anand, G. Honari, T. Hasan, P. Elson, and E. V. Maytin, "Low-dose methotrexate enhances aminolevulinate-based photodynamic therapy in skin carcinoma cells in vitro and in vivo," Clin. Cancer Res. 15(10), 3333-3343 (2009).
14. S. Gerscher, J. P. Connelly, G. M. Beijersbergen Van Henegouwen, A. J. MacRobert, P. Watt, and L. E. Rhodes, "A quantitative assessment of protoporphyrin IX metabolism and phototoxicity in human skin following dose-controlled delivery of the prodrugs 5-aminolaevulinic acid and 5-aminolaevulinic acid-n-pentylester," Br. J. Dermatol. 144(5), 983-990 (2001).
15. S. Gerscher, J. P. Connelly, J. Griffiths, S. B. Brown, A. J. MacRobert, G. Wong, and L. E. Rhodes, "Comparison of the pharmacokinetics and phototoxicity of protoporphyrin IX metabolized from 5-aminolevulinic acid and two derivatives in human skin in vivo," Photochem. Photobiol. 72(4), 569-574 (2000).
16. S. Andersson-Engels, G. Canti, R. Cubeddu, C. Eker, C. af Klinteberg, A. Pifferi, K. Svanberg, S. Svanberg, P. Taroni, G. Valentini, and I. Wang, "Preliminary evaluation of two fluorescence imaging methods for the detection and the delineation of basal cell carcinomas of the skin," Lasers Surg. Med. 26(1), 76-82 (2000).
17. R. Na, I. M. Stender, and H. C. Wulf, "Can autofluorescence demarcate basal cell carcinoma from normal skin? A comparison with protoporphyrin IX fluorescence," Acta Derm Venereol 81(4), 246-249 (2001).
18. B. Stenquist, M. B. Ericson, C. Strandeberg, L. Molne, A. Rosen, O. Larko, and A. M. Wennberg, "Bispectral fluorescence imaging of aggressive basal cell carcinoma combined with histopathological mapping: a preliminary study indicating a possible adjunct to Mohs micrographic surgery," Br. J. Dermatol. 154(2), 305-309 (2006).
19. R. Alkalay, J. Alcalay, A. Maly, A. Ingber, C. Fritsch, T. Ruzicka, and C. D. Enk, "Fluorescence imaging for the demarcation of basal cell carcinoma tumor borders," J. Drugs Dermatol. 7(11), 1033-1037 (2008).
20. E. V. Maytin, S. Anand, C. Baran, G. Honari, S. Lohser, A. Kyei, P. Bailin, and B. W. Pogue, "Enhancement and optimization of PpIX-based photodynamic therapy of skin cancer: translational studies from bench to clinic," in Mechanisms and Techniques in Photodynamic Therapy XVIII, D. Kessel, Ed., Proc. SPIE 7164, 71640K (2009).